AML-derived mutations of FMS-like tyrosine kinase 3 (FLT3) upregulated SUCLG1 to induce POLRMT hyposuccinylation, resulting in enhanced mitobiogenesis and leukemia progression. This evidence concerns the gene SUCLG1 and leukemia.